Cargando…
Clinical Outcomes of Posterior Lumbar Interbody Fusion versus Minimally Invasive Transforaminal Lumbar Interbody Fusion in Three-Level Degenerative Lumbar Spinal Stenosis
The aim of this study was to directly compare the clinical outcomes of posterior lumbar interbody fusion (PLIF) and minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) in three-level lumbar spinal stenosis. This retrospective study involved a total of 60 patients with three-level de...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056235/ https://www.ncbi.nlm.nih.gov/pubmed/27747244 http://dx.doi.org/10.1155/2016/9540298 |
_version_ | 1782458857773072384 |
---|---|
author | Fan, Guoxin Wu, Xinbo Yu, Shunzhi Sun, Qi Guan, Xiaofei Zhang, Hailong Gu, Xin He, Shisheng |
author_facet | Fan, Guoxin Wu, Xinbo Yu, Shunzhi Sun, Qi Guan, Xiaofei Zhang, Hailong Gu, Xin He, Shisheng |
author_sort | Fan, Guoxin |
collection | PubMed |
description | The aim of this study was to directly compare the clinical outcomes of posterior lumbar interbody fusion (PLIF) and minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) in three-level lumbar spinal stenosis. This retrospective study involved a total of 60 patients with three-level degenerative lumbar spinal stenosis who underwent MIS-TLIF or PLIF from January 2010 to February 2012. Back and leg visual analog scale (VAS), Oswestry Disability Index (ODI), and Short Form-36 (SF-36) scale were used to assess the pain, disability, and health status before surgery and postoperatively. In addition, the operating time, estimated blood loss, and hospital stay were also recorded. There were no significant differences in back VAS, leg VAS, ODI, SF-36, fusion condition, and complications at 12-month follow-up between the two groups (P > 0.05). However, significantly less blood loss and shorter hospital stay were observed in MIS-TLIF group (P < 0.05). Moreover, patients undergoing MIS-TLIF had significantly lower back VAS than those in PLIF group at 6-month follow-up (P < 0.05). Compared with PLIF, MIS-TLIF might be a prior option because of noninferior efficacy as well as merits of less blood loss and quicker recovery in treating three-level lumbar spinal stenosis. |
format | Online Article Text |
id | pubmed-5056235 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-50562352016-10-16 Clinical Outcomes of Posterior Lumbar Interbody Fusion versus Minimally Invasive Transforaminal Lumbar Interbody Fusion in Three-Level Degenerative Lumbar Spinal Stenosis Fan, Guoxin Wu, Xinbo Yu, Shunzhi Sun, Qi Guan, Xiaofei Zhang, Hailong Gu, Xin He, Shisheng Biomed Res Int Clinical Study The aim of this study was to directly compare the clinical outcomes of posterior lumbar interbody fusion (PLIF) and minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) in three-level lumbar spinal stenosis. This retrospective study involved a total of 60 patients with three-level degenerative lumbar spinal stenosis who underwent MIS-TLIF or PLIF from January 2010 to February 2012. Back and leg visual analog scale (VAS), Oswestry Disability Index (ODI), and Short Form-36 (SF-36) scale were used to assess the pain, disability, and health status before surgery and postoperatively. In addition, the operating time, estimated blood loss, and hospital stay were also recorded. There were no significant differences in back VAS, leg VAS, ODI, SF-36, fusion condition, and complications at 12-month follow-up between the two groups (P > 0.05). However, significantly less blood loss and shorter hospital stay were observed in MIS-TLIF group (P < 0.05). Moreover, patients undergoing MIS-TLIF had significantly lower back VAS than those in PLIF group at 6-month follow-up (P < 0.05). Compared with PLIF, MIS-TLIF might be a prior option because of noninferior efficacy as well as merits of less blood loss and quicker recovery in treating three-level lumbar spinal stenosis. Hindawi Publishing Corporation 2016 2016-09-26 /pmc/articles/PMC5056235/ /pubmed/27747244 http://dx.doi.org/10.1155/2016/9540298 Text en Copyright © 2016 Guoxin Fan et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Fan, Guoxin Wu, Xinbo Yu, Shunzhi Sun, Qi Guan, Xiaofei Zhang, Hailong Gu, Xin He, Shisheng Clinical Outcomes of Posterior Lumbar Interbody Fusion versus Minimally Invasive Transforaminal Lumbar Interbody Fusion in Three-Level Degenerative Lumbar Spinal Stenosis |
title | Clinical Outcomes of Posterior Lumbar Interbody Fusion versus Minimally Invasive Transforaminal Lumbar Interbody Fusion in Three-Level Degenerative Lumbar Spinal Stenosis |
title_full | Clinical Outcomes of Posterior Lumbar Interbody Fusion versus Minimally Invasive Transforaminal Lumbar Interbody Fusion in Three-Level Degenerative Lumbar Spinal Stenosis |
title_fullStr | Clinical Outcomes of Posterior Lumbar Interbody Fusion versus Minimally Invasive Transforaminal Lumbar Interbody Fusion in Three-Level Degenerative Lumbar Spinal Stenosis |
title_full_unstemmed | Clinical Outcomes of Posterior Lumbar Interbody Fusion versus Minimally Invasive Transforaminal Lumbar Interbody Fusion in Three-Level Degenerative Lumbar Spinal Stenosis |
title_short | Clinical Outcomes of Posterior Lumbar Interbody Fusion versus Minimally Invasive Transforaminal Lumbar Interbody Fusion in Three-Level Degenerative Lumbar Spinal Stenosis |
title_sort | clinical outcomes of posterior lumbar interbody fusion versus minimally invasive transforaminal lumbar interbody fusion in three-level degenerative lumbar spinal stenosis |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056235/ https://www.ncbi.nlm.nih.gov/pubmed/27747244 http://dx.doi.org/10.1155/2016/9540298 |
work_keys_str_mv | AT fanguoxin clinicaloutcomesofposteriorlumbarinterbodyfusionversusminimallyinvasivetransforaminallumbarinterbodyfusioninthreeleveldegenerativelumbarspinalstenosis AT wuxinbo clinicaloutcomesofposteriorlumbarinterbodyfusionversusminimallyinvasivetransforaminallumbarinterbodyfusioninthreeleveldegenerativelumbarspinalstenosis AT yushunzhi clinicaloutcomesofposteriorlumbarinterbodyfusionversusminimallyinvasivetransforaminallumbarinterbodyfusioninthreeleveldegenerativelumbarspinalstenosis AT sunqi clinicaloutcomesofposteriorlumbarinterbodyfusionversusminimallyinvasivetransforaminallumbarinterbodyfusioninthreeleveldegenerativelumbarspinalstenosis AT guanxiaofei clinicaloutcomesofposteriorlumbarinterbodyfusionversusminimallyinvasivetransforaminallumbarinterbodyfusioninthreeleveldegenerativelumbarspinalstenosis AT zhanghailong clinicaloutcomesofposteriorlumbarinterbodyfusionversusminimallyinvasivetransforaminallumbarinterbodyfusioninthreeleveldegenerativelumbarspinalstenosis AT guxin clinicaloutcomesofposteriorlumbarinterbodyfusionversusminimallyinvasivetransforaminallumbarinterbodyfusioninthreeleveldegenerativelumbarspinalstenosis AT heshisheng clinicaloutcomesofposteriorlumbarinterbodyfusionversusminimallyinvasivetransforaminallumbarinterbodyfusioninthreeleveldegenerativelumbarspinalstenosis |